Invention Grant
- Patent Title: Cores for technetium radiopharmaceuticals
- Patent Title (中): 锝放射性药物的核心
-
Application No.: US09976014Application Date: 2001-10-15
-
Publication No.: US06515112B2Publication Date: 2003-02-04
- Inventor: Colin M. Archer , Jonathan R. Dilworth , Panna Jobanputra , Ian A. Latham , Russell M. Thompson
- Applicant: Colin M. Archer , Jonathan R. Dilworth , Panna Jobanputra , Ian A. Latham , Russell M. Thompson
- Priority: GB8919488 19890829
- Main IPC: C07F500
- IPC: C07F500

Abstract:
A 99mTc complex which contains the moiety Tc═NR, Tc—N═NY or Tc(—N═NY)2, and as a synthetic organic ligand which confers biological target-seeking properties on the technetium complex, where: R is an aryl group, a substituted or unsubstituted alkyl group or the group —NR1R2; Y is an aryl group or a substituted or unsubstituted alkyl group; R1 and R2 are H, aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and are the same or different provided that both are not hydrogen; where at least one of the R or Y groups comprises an aryl group which chelates the 99mTc.
Public/Granted literature
- US20020082398A1 Cores for technetium radiopharmaceuticals Public/Granted day:2002-06-27
Information query